Replacing Animal Testing with Stem Cell-Organoids : Advantages and Limitations
Stem Cell Reviews and Reports · 2024-08 · 20 (6) · 1375-1386
DOI: 10.1007/s12015-024-10723-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stem Cell Reviews and Reports, online erschienen am 19.04.2024. Verfasst von Guiyoung Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biopharmaceutical and Medical Sciences, Health & Wellness College, Sungshin Women's University, 55, Dobong-ro 76ga-gil, Gangbuk-gu, Seoul, …. Hauptthemen laut MEDLINE: Organoids. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute.
Abstract (Originalsprache)
Various groups including animal protection organizations, medical organizations, research centers, and even federal agencies such as the U.S. Food and Drug Administration, are working to minimize animal use in scientific experiments. This movement primarily stems from animal welfare and ethical concerns. However, recent advances in technology and new studies in medicine have contributed to an increase in animal experiments throughout the years. With the rapid increase in animal testing, concerns arise including ethical issues, high cost, complex procedures, and potential inaccuracies. Alternative solutions have recently been investigated to address the problems of animal testing. Some of these technologies are related to stem cell technologies, such as organ-on-a-chip, organoids, and induced pluripotent stem cell models. The aim of the review is to focus on stem cell related methodologies, such as organoids, that can serve as an alternative to animal testing and discuss its advantages and limitations, alongside regulatory considerations. Although stem cell related methodologies has shortcomings, it has potential to replace animal testing. Achieving this requires further research on stem cells, with potential societal and technological benefits. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Biopharmaceutical and Medical Sciences, Health & Wellness College, Sungshin Women's University, 55, Dobong-ro 76ga-gil, Gangbuk-gu, Seoul, Republic of Korea.
- CiSTEM laboratory, Convergent Research Consortium for Immunologic Disease, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
- Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, Institute of Medical Science, College of Medicine, The Catholic University of Korea, 4 3, Seoul, 06591, Republic of Korea.
- Department of Biomedicine & Health Sciences, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
- Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea.
- Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea. givingtreemax@gmail.com.
ORCID-Profile: Yoojun Nam
Förderung
- Korea Health Industry Development Institute
Zitieren
APA
Park, G., Rim, Y. A., Sohn, Y., Nam, Y., & Ju, J. H. (2024). Replacing Animal Testing with Stem Cell-Organoids : Advantages and Limitations. Stem Cell Reviews and Reports, 20(6), 1375-1386. https://doi.org/10.1007/s12015-024-10723-5
Vancouver
Park G, Rim YA, Sohn Y, Nam Y, Ju JH. Replacing Animal Testing with Stem Cell-Organoids : Advantages and Limitations. Stem Cell Reviews and Reports. 2024;20(6):1375-1386. doi:10.1007/s12015-024-10723-5
BibTeX
@article{Park2024,
author = {Park, Guiyoung and Rim, Yeri Alice and Sohn, Yeowon and Nam, Yoojun and Ju, Ji Hyeon},
title = {Replacing Animal Testing with Stem Cell-Organoids : Advantages and Limitations},
journal = {Stem Cell Reviews and Reports},
year = {2024},
volume = {20},
number = {6},
pages = {1375--1386},
doi = {10.1007/s12015-024-10723-5}
}
EUVIMED